Misclassification and Bias in Military Studies of Mefloquine.
作者信息
Lee Nevin Remington
机构信息
Department of Environmental Health and Engineering Johns Hopkins Bloomberg School of Public Health Baltimore, Maryland E-mail:
出版信息
Am J Trop Med Hyg. 2017 Jul;97(1):305. doi: 10.4269/ajtmh.17-0246.
Abstract
摘要
相似文献
1
Misclassification and Bias in Military Studies of Mefloquine.
Am J Trop Med Hyg. 2017 Jul;97(1):305. doi: 10.4269/ajtmh.17-0246.
2
Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.
Malar J. 2008 Feb 11;7:30. doi: 10.1186/1475-2875-7-30.
3
Mefloquine for malaria prophylaxis in military personnel.
BMJ Mil Health. 2020 Nov;166(E):e1-e2. doi: 10.1136/jramc-2019-001295. Epub 2020 Feb 20.
4
MPs may hold inquiry into safety of using antimalarial mefloquine in military.
BMJ. 2015 Sep 11;351:h4868. doi: 10.1136/bmj.h4868.
5
Value of mefloquine chemoprophylaxis in military personnel.
BMJ. 2015 Dec 9;351:h6584. doi: 10.1136/bmj.h6584.
6
Malaria in Brazilian military personnel deployed to Angola.
J Travel Med. 2000 Sep-Oct;7(5):275-82. doi: 10.2310/7060.2000.00077.
7
Better approach needed to detect and treat military personnel with adverse effects from mefloquine.
BMJ. 2016 Feb 10;352:i838. doi: 10.1136/bmj.i838.
8
Mefloquine for malarial prophylaxis in military personnel.
BMJ. 2015 Nov 3;351:h5797. doi: 10.1136/bmj.h5797.
9
Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor.
J Travel Med. 2007 Jul-Aug;14(4):226-32. doi: 10.1111/j.1708-8305.2007.00122.x.
10
Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment.
Eur J Clin Pharmacol. 2007 Mar;63(3):271-8. doi: 10.1007/s00228-006-0247-3. Epub 2007 Jan 11.
引用本文的文献
1
Bias and Confounding in Studies of Chronic Mental Health Effects from Mefloquine Exposure.
Am J Trop Med Hyg. 2019 Feb;100(2):476-477. doi: 10.4269/ajtmh.18-0771a.
本文引用的文献
1
2
Neuropsychiatric Outcomes After Mefloquine Exposure Among U.S. Military Service Members.
Am J Trop Med Hyg. 2017 Jan 11;96(1):159-166. doi: 10.4269/ajtmh.16-0390. Epub 2016 Nov 14.
3
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data.
Drugs R D. 2017 Mar;17(1):199-210. doi: 10.1007/s40268-016-0167-3.
4
Prolonged Neuropsychiatric Symptoms in a Military Service Member Exposed to Mefloquine.
Drug Saf Case Rep. 2016 Dec;3(1):7. doi: 10.1007/s40800-016-0030-z.
5
Falling rates of malaria among U.S. military service members in Afghanistan substantiate findings of high compliance with daily chemoprophylaxis.
Am J Trop Med Hyg. 2012 Nov;87(5):957-958. doi: 10.4269/ajtmh.2012.12-0277a.
6
Mefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007.
Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):206-10. doi: 10.1002/pds.1879.
7
Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan.
Malar J. 2008 Feb 11;7:30. doi: 10.1186/1475-2875-7-30.
8
Mefloquine use and hospitalizations among US service members, 2002-2004.
Am J Trop Med Hyg. 2006 May;74(5):744-9.
Zotero 插件